Oberg, Ann L.
Heinzen, Ethan P.
Hou, Xiaonan
Al Hilli, Mariam M.
Hurley, Rachel M.
Wahner Hendrickson, Andrea E.
Goergen, Krista M.
Larson, Melissa C.
Becker, Marc A.
Eckel-Passow, Jeanette E.
Maurer, Matthew J.
Kaufmann, Scott H.
Haluska, Paul
Weroha, S. John
Funding for this research was provided by:
NCI (P50-CA136393, P50-CA136393, P50-CA136393, P50-CA136393, P50-CA136393, P50-CA136393, P50-CA136393, P50-CA136393, P50-CA108961, P50-CA136393, P50-CA136393, P50-CA136393, P50-CA136393)
The Fred C. and Katherine B. Andersen Foundation
Mayo Foundation for Education and Research
NIH (T32-GM65841)
Ovarian Cancer Research Fund
Article History
Received: 25 September 2020
Accepted: 22 March 2021
First Online: 13 April 2021
Competing interests
: PH received funding and MK-4827 from Merck and Tesaro to perform work contained herein. PH is currently employed by and holds stock in Bristol-Myers Squibb. All others report no conflicts of interest.